References

Vij R, Machado RF. Pulmonary complications of hemoglobinopathies. Chest. 2010; 138:973-983 https://doi.org/10.1378/chest.10-0317
Helmi N, Bashir M, Shireen A, Ahmed IM. Thalassemia review: features, dental considerations and management. Electron Physician. 2017; 9:4003-4008 https://doi.org/10.19082/4003
Gosein M, Maharaj P, Balkaransingh P Imaging features of thalassaemia. Br J Radiol. 2019; 92 https://doi.org/10.1259/bjr.20180658
Clevenger B, Kelleher A. Hazards of blood transfusion in adults and children. Cont Educ Anaesth Crit Care Pain. 2014; 14:112-118
Beck W.Cambridge, MA: MIT; 1998
Habibian N, Alipour A, Rezaianzadeh A. Association between iron deficiency anemia and febrile convulsion in 3-to 60-month-old children: a systematic review and meta-analysis. Iran J Med Sci. 2014; 39:496-505
Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010; 5 https://doi.org/10.1186/1750-1172-5-13
Jankulovski N, Antovic S, Kuzmanovska B, Mitevski A. Splenectomy for haematological disorders. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014; 35:181-187
National Organization for Rare Disorders. Beta Thalassema. https://rarediseases.org/rare-diseases/thalassemia-major/
Zhu G, Wu X, Zhang X Clinical and imaging findings in thalassemia patients with extramedullary hematopoiesis. Clin Imaging. 2012; 36:475-482 https://doi.org/10.1016/j.clinimag.2011.11.019
Karakas S, Tellioglu AM, Bilgin M Craniofacial characteristics of thalassemia major patients. Eurasian J Med. 2016; 48:204-208 https://doi.org/10.5152/eurasianjmed.2016.150013
Mallya S, Lam E.St Louis, MO, USA: Mosby; 2018
Koenig L, Tamimi D, Petrikowski C, Perschbacher S., 2nd edn. : Elsevier; 2017
Som P, Curtin H.: Elsevier Health Sciences; 2011
Dave M, Loughlin A, Walker E, Davies J. Challenges in plain film radiographic diagnosis for the dental team: a review of the maxillary sinus. Br Dent J. 2020; 228:587-594 https://doi.org/10.1038/s41415-020-1524-8
Baldini M, Marcon A, Cassin R Beta-thalassaemia intermedia: evaluation of endocrine and bone complications. Biomed Res Int. 2014; 2014 https://doi.org/10.1155/2014/174581
Rossi F, Perrotta S, Bellini G Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels. Haematologica. 2014; 99:1876-1884 https://doi.org/10.3324/haematol.2014.104463
De Sanctis V, Soliman AT, Elsedfy H Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr Endocrinol Rev. 2013; 11:167-180

Manifestations of beta thalassaemia in the dental setting: a case report

From Volume 49, Issue 8, September 2022 | Pages 646-649

Authors

Ria Radia

BDS(Hons)

Dental Core Trainee, The Royal London Dental Hospital, Turner Street

Articles by Ria Radia

Amanda Loughlin

BDS, MFDS, DDMFR

Consultant in Dental and Maxillofacial Radiology, Barts Health NHS Trust, London

Articles by Amanda Loughlin

Ashok Adams

MRCP, FRCR

Consultant Neuroradiologist, Barts Health NHS Trust, London

Articles by Ashok Adams

Abstract

The craniofacial manifestations of beta thalassaemia are widely reported, and occur as a result of inadequate haematopoiesis leading to marrow space expansion. Secondarily, extramedullary haematopoiesis can occur throughout the body, although this is rarely reported in the paranasal sinuses. We discuss the systemic and craniofacial manifestations of beta thalassaemia major, with a focus on the radiological findings, as illustrated in a case of a 55-year-old male patient who was referred to the dental hospital as a result of complications of thalassaemia. This case report focuses on the effects of thalassaemia that may be encountered in a dental setting and highlights the radiological findings that clinicians should be aware of.

CPD/Clinical Relevance: Dental and craniofacial manifestations, and their management, are discussed for patients with beta thalassaemia.

Article

Thalassaemia is a genetic disorder involving abnormal haemoglobin formation.1 The haemoglobin molecule consists of both alpha and beta chains. In thalassaemia, the alpha or beta chains in the haemoglobin are defective as a result of mutation in the alpha or beta globin genes, resulting in a reduced oxygen-carrying capacity of the blood. This leads to overproduction of red blood cells and abnormal haemoglobin in the body. Thalassaemia can be described as either alpha or beta thalassaemia depending on which chains of the haemoglobin molecule are affected.2

There are several subtypes of the disease, including the minor, intermediate and major forms, which all present with varying severity. Beta thalassaemia is mainly found in Mediterranean, African and Asian populations.

Thalassaemias are a quantitative problem of haemoglobin synthesis where not enough ‘normal’ haemoglobin is produced to cope with the oxygenation demands of the body (ineffective erythropoiesis). In beta thalassaemias, there is also haemolysis of the defective circulating red blood cells. These phenomena together result in severe anaemia. The body may compensate for reduced oxygen carrying capacity through hyperplasia of bone marrow. Individuals with thalassaemia major often require regular blood transfusions to counteract the chronic anaemia that accompanies the disease.2

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available